WST SG&A Expense Growth
West Pharmaceutical Services · SG&A Expense Growth

WST SG&A Expense Growth
Latest reported16.13%period ending
WST FY SG&A Growth (YoY) (0.00% → 16.13%)
Latest values, visible window
High-resolution chart · PNG
WST sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 16.13% | |
| -4.2162% | |
| 11.5178% | |
| -12.4344% | |
| 19.8344% | |
| 10.7444% | |
| 3.7277% | |
| 6.8699% | |
| 2.5855% | |
| 2.9185% | |
| 1.8802% | |
| -2.6394% | |
| 7.7029% | |
| 14.1287% | |
| 1.8114% | |
| 5.6275% | |
| 11.5505% | |
| 4.459% | |
| 5.3177% | |
| 28.8256% | |
| 15.6379% | |
| -12.4324% | |
| 34.3826% | |
| 12.5341% | |
| 8.4195% | |
| -13.0937% | |
| 10.4965% | |
| 0.4274% | |
| -3.5714% | |
| 4.1488% | |
| 1.3043% | |
| 8.6614% | |
| 11.2084% | |
| -32.8235% | |
| 47.0588% | |
| 26.7544% | |
| 9.8795% | |
| 28.882% | |
| 7.6923% | |
| 12.406% | |
| 0% |